NewYork-Presbyterian Lower Manhattan Hospital is a nonprofit, acute care, teaching hospital in New York City and is the only hospital in Lower Manhattan south of Greenwich Village. It is part of the NewYork-Presbyterian Healthcare System and one of the main campuses of NewYork-Presbyterian Hospital.

During the past decade, New York Downtown Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Downtown Hospital" #1 sponsor was "Advaxis, Inc." with 1 trials, followed by "Albert Einstein College of Medicine" with 1 trials sponsored, "MEI Pharma, Inc." with 1 trials sponsored, "New York Presbyterian Hospital" with 1 trials sponsored and "Precision Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Downtown Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "New York Downtown Hospital" are "Cervical Intraepithelial Neoplasia" (2 trials), "Fallopian Tube Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Breast Cancer" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "New York Downtown Hospital" in a lesser frequency.

Most popular intervention types in "New York Downtown Hospital" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "A007" (1 trials), "ADXS11-001 (Lm-LLO-E7)" (1 trials), "Cvac" (1 trials) and "Placebo Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Downtown Hospital" are 6 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "New York Downtown Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in New York Downtown Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New York Downtown Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".